Message from the Chair

Welcome to the Milton and Carroll Petrie Department of Urology at the Icahn School of Medicine, Mount Sinai Health System. As one of the largest academic urology departments in NYC, spread across Mount Sinai Hospital, Beth Israel Medical Center, Beth Israel Brooklyn, Mount Sinai Queens, and Saint Luke's-Roosevelt, we are second to none with respect to breadth of services, surgical skill, depth of clinical experience, outstanding outcomes, innovative programs of research and discovery, and training opportunities.

We care for men and women at all stages of life and treat both localized and advanced disease. Concern for our patients' welfare begins at their first visit, and continues through diagnosis, treatment and ongoing management of a full range of genitourinary conditions, including prostate, bladder and kidney cancers, prostate health, sexual and voiding dysfunctions, men's health, stone diseases and congenital and acquired pediatric disorders. We are leaders in robotic surgery, for both adults and children. Our comprehensive prostate cancer program is headed by world leaders in active surveillance, focal therapy, targeted MRI guided biopsy, radiation therapy, robotic and open surgery, pathology, medical oncology, precision medicine and sexual and urinary rehabilitation. Our team oversees numerous clinical trials exploring new diagnostic and treatment alternatives. We have a holistic approach towards healing and have a dedicated team providing alternative medical care, exercise, yoga and meditation. Our female urology program is directed towards urological diseases of women in all stages of life. Our men's health program is one visit comprehensive program addressing all health needs for men at one location.

We are dedicated educators and researchers, as well as clinicians with advanced fellowship training in specific sub specialties, on the cutting edge of medical and technological advances in our field. Our department is one of the few in the country with behavioral health scientists on our faculty who study the psychosocial impact of cancer on patients and are designing programs to help these patients navigate through some of the most challenging aspects of their disease.

We are highly engaged in translational research involving genomics, targeted drug therapies, precision urology, system biology, imaging, outcomes, robotic surgery and computer based decision models. We have PhDs, MPHs, MDs and several young investigators in the department who either work on bench research or animal models. We have dedicated programs for medical students, residents and undergrads for conducting meaningful research under faculty supervision. Our robotic simulator program offers a summer rotation for residents and welcomes medical students from all over the world. Our residents are among the best and brightest, and we are gratified that many of them pursue prestigious fellowships post residency.

We hold a strong belief in the value of education and development: learning from one another and our global peers and in turn, sharing our skills and insights with them in order to burnish our individual and collective expertise.

I consider it an honor and privilege to be leading the Department of Urology at Mount Sinai. It is a highly satisfying and rewarding place for all employees and staff. Such an environment results in better and more compassionate patient care, and as a result, exceptional outcomes, our highest goal.

Ash Tewari, MD, MCh, FRCS
Professor and Chairman
Milton and Carroll Petrie Department of Urology